Literature DB >> 11023460

Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women.

M Biasin1, S L Caputo, L Speciale, F Colombo, L Racioppi, A Zagliani, C Blé, F Vichi, L Cianferoni, A M Masci, M L Villa, P Ferrante, F Mazzotta, M Clerici.   

Abstract

Immune parameters were analyzed in peripheral blood mononuclear cells (PBMC) and cervical mucosa biopsy specimens of human immunodeficiency virus (HIV)-seronegative women sexually exposed to HIV (exposed seronegative [ESN]), HIV-infected women, and healthy women without HIV exposure. HIV was not detected in PBMC or cervical mucosa biopsy specimens of ESN women. However, interleukin (IL)-6, IL-10, IL-12, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha and -beta mRNA were elevated in PBMC and cervical mucosa biopsy specimens of ESN and HIV-infected women; CCR5 and CXCR4 mRNA were augmented in cervical mucosa biopsy specimens, but not in PBMC, of ESN and HIV-infected women; HIV-specific IFN-gamma-secreting cells were detected in vaginal washes of ESN and HIV-infected women; and phenotypic alterations were present in PBMC of ESN women. These results suggest that active HIV infection is not required for T cell activation; immune alterations occur in women in whom HIV infection cannot be detected virologically or clinically.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11023460     DOI: 10.1086/315873

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.

Authors:  Peter J Kuebler; Megha L Mehrotra; Brian I Shaw; Kaitlyn S Leadabrand; Jeffrey M Milush; Vanessa A York; Patricia Defechereux; Robert M Grant; Esper G Kallás; Douglas F Nixon
Journal:  J Infect Dis       Date:  2015-08-26       Impact factor: 5.226

2.  Systemic cytokine levels show limited correlation with risk of HIV-1 acquisition.

Authors:  Dara A Lehman; Keshet Ronen; Catherine A Blish; Jared M Baeten; Zahra Jalalian-Lechak; Walter Jaoko; Kishorchandra Mandaliya; Barbra A Richardson; R Scott McClelland; Julie Overbaugh
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

3.  S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.

Authors:  Krystal Colón; David W Speicher; Peter Smith; Mack Taylor; David S Metzger; Luis J Montaner; Costin Tomescu
Journal:  J Acquir Immune Defic Syndr       Date:  2019-02-01       Impact factor: 3.731

4.  Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

Authors:  Vivek Naranbhai; Salim S Abdool Karim; Marcus Altfeld; Natasha Samsunder; Raveshni Durgiah; Sengeziwe Sibeko; Quarraisha Abdool Karim; William H Carr
Journal:  J Infect Dis       Date:  2012-07-24       Impact factor: 5.226

5.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

Authors:  R Kaul; T Dong; F A Plummer; J Kimani; T Rostron; P Kiama; E Njagi; E Irungu; B Farah; J Oyugi; R Chakraborty; K S MacDonald; J J Bwayo; A McMichael; S L Rowland-Jones
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

6.  Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state.

Authors:  Elijah M Songok; Ma Luo; Ben Liang; Paul Mclaren; Nadine Kaefer; Winnie Apidi; Genevieve Boucher; Joshua Kimani; Charles Wachihi; Rafick Sekaly; Keith Fowke; Blake T Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

7.  T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use.

Authors:  Eveli Kallas; Kristi Huik; Silver Türk; Merit Pauskar; Ene-Ly Jõgeda; Marina Šunina; Tõnis Karki; Don Des Jarlais; Anneli Uusküla; Radko Avi; Irja Lutsar
Journal:  Viral Immunol       Date:  2016-08-26       Impact factor: 2.257

8.  HIV-1-exposed seronegative individuals show alteration in TLR expression and pro-inflammatory cytokine production ex vivo: An innate immune quiescence status?

Authors:  Juan C Hernandez; Georges St Laurent; Silvio Urcuqui-Inchima
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

9.  Potent neutralizing serum immunoglobulin A (IgA) in human immunodeficiency virus type 2-exposed IgG-seronegative individuals.

Authors:  Qin Lizeng; Charlotta Nilsson; Samer Sourial; Sören Andersson; Olav Larsen; Peter Aaby; Mariethe Ehnlund; Ewa Björling
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 10.  Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Authors:  Ruizhong Shen; Phillip D Smith
Journal:  Am J Reprod Immunol       Date:  2014-01-16       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.